These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 18996017)

  • 1. Convergent synthesis and cruzain inhibitory activity of novel 2-(N'-benzylidenehydrazino)-4-trifluoromethyl-pyrimidines.
    Zanatta N; Amaral SS; Dos Santos JM; de Mello DL; Fernandes Lda S; Bonacorso HG; Martins MA; Andricopulo AD; Borchhardt DM
    Bioorg Med Chem; 2008 Dec; 16(24):10236-43. PubMed ID: 18996017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates.
    Romeiro NC; Aguirre G; Hernández P; González M; Cerecetto H; Aldana I; Pérez-Silanes S; Monge A; Barreiro EJ; Lima LM
    Bioorg Med Chem; 2009 Jan; 17(2):641-52. PubMed ID: 19110434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cruzain inhibition by hydroxymethylnitrofurazone and nitrofurazone: investigation of a new target in Trypanosoma cruzi.
    Trossini GH; Malvezzi A; T-do Amaral A; Rangel-Yagui CO; Izidoro MA; Cezari MH; Juliano L; Chin CM; Menezes CM; Ferreira EI
    J Enzyme Inhib Med Chem; 2010 Feb; 25(1):62-7. PubMed ID: 20030510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK.
    Waelchli R; Bollbuck B; Bruns C; Buhl T; Eder J; Feifel R; Hersperger R; Janser P; Revesz L; Zerwes HG; Schlapbach A
    Bioorg Med Chem Lett; 2006 Jan; 16(1):108-12. PubMed ID: 16236504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosoma cruzi agents.
    dos Santos Filho JM; Leite AC; de Oliveira BG; Moreira DR; Lima MS; Soares MB; Leite LF
    Bioorg Med Chem; 2009 Sep; 17(18):6682-91. PubMed ID: 19683450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Design, Synthesis and Trypanocidal Activity of Dipeptidyl Nitriles as Cruzain Inhibitors.
    Avelar LA; Camilo CD; de Albuquerque S; Fernandes WB; Gonçalez C; Kenny PW; Leitão A; McKerrow JH; Montanari CA; Orozco EV; Ribeiro JF; Rocha JR; Rosini F; Saidel ME
    PLoS Negl Trop Dis; 2015; 9(7):e0003916. PubMed ID: 26173110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain.
    Espíndola JW; Cardoso MV; Filho GB; Oliveira E Silva DA; Moreira DR; Bastos TM; Simone CA; Soares MB; Villela FS; Ferreira RS; Castro MC; Pereira VR; Murta SM; Sales Junior PA; Romanha AJ; Leite AC
    Eur J Med Chem; 2015 Aug; 101():818-35. PubMed ID: 26231082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of a new series of substituted acyl(thio)urea and thiadiazolo [2,3-a] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.
    Sun C; Zhang X; Huang H; Zhou P
    Bioorg Med Chem; 2006 Dec; 14(24):8574-81. PubMed ID: 16979342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.
    Choe Y; Brinen LS; Price MS; Engel JC; Lange M; Grisostomi C; Weston SG; Pallai PV; Cheng H; Hardy LW; Hartsough DS; McMakin M; Tilton RF; Baldino CM; Craik CS
    Bioorg Med Chem; 2005 Mar; 13(6):2141-56. PubMed ID: 15727867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Cruzain docking, and in vitro studies of aryl-4-oxothiazolylhydrazones against Trypanosoma cruzi.
    Leite AC; Moreira DR; Cardoso MV; Hernandes MZ; Alves Pereira VR; Silva RO; Kiperstok AC; Lima Mda S; Soares MB
    ChemMedChem; 2007 Sep; 2(9):1339-45. PubMed ID: 17628867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural design, synthesis and structure-activity relationships of thiazolidinones with enhanced anti-Trypanosoma cruzi activity.
    Moreira DR; Leite AC; Cardoso MV; Srivastava RM; Hernandes MZ; Rabello MM; da Cruz LF; Ferreira RS; de Simone CA; Meira CS; Guimaraes ET; da Silva AC; dos Santos TA; Pereira VR; Soares MB
    ChemMedChem; 2014 Jan; 9(1):177-88. PubMed ID: 24203393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biochemical evaluation of novel cruzain inhibitors with potential application in the treatment of Chagas' disease.
    Siles R; Chen SE; Zhou M; Pinney KG; Trawick ML
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4405-9. PubMed ID: 16781147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationship of aminopyrimidine IKK2 inhibitors.
    Bingham AH; Davenport RJ; Fosbeary R; Gowers L; Knight RL; Lowe C; Owen DA; Parry DM; Pitt WR
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3622-7. PubMed ID: 18501602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cruzain inhibitors: efforts made, current leads and a structural outlook of new hits.
    Martinez-Mayorga K; Byler KG; Ramirez-Hernandez AI; Terrazas-Alvares DE
    Drug Discov Today; 2015 Jul; 20(7):890-8. PubMed ID: 25697479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological evaluation, and structure-activity relationships of potent noncovalent and nonpeptidic cruzain inhibitors as anti-Trypanosoma cruzi agents.
    Ferreira RS; Dessoy MA; Pauli I; Souza ML; Krogh R; Sales AI; Oliva G; Dias LC; Andricopulo AD
    J Med Chem; 2014 Mar; 57(6):2380-92. PubMed ID: 24533839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aryl ureas represent a new class of anti-trypanosomal agents.
    Du X; Hansell E; Engel JC; Caffrey CR; Cohen FE; McKerrow JH
    Chem Biol; 2000 Sep; 7(9):733-42. PubMed ID: 10980453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure-activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: molecular modeling, CoMFA and CoMSIA studies.
    Trossini GH; Guido RV; Oliva G; Ferreira EI; Andricopulo AD
    J Mol Graph Model; 2009 Aug; 28(1):3-11. PubMed ID: 19376735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors.
    Chern JH; Shia KS; Hsu TA; Tai CL; Lee CC; Lee YC; Chang CS; Tseng SN; Shih SR
    Bioorg Med Chem Lett; 2004 May; 14(10):2519-25. PubMed ID: 15109643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Based Virtual Screening and In Vitro Evaluation of New
    Herrera-Mayorga V; Lara-Ramírez EE; Chacón-Vargas KF; Aguirre-Alvarado C; Rodríguez-Páez L; Alcántara-Farfán V; Cordero-Martínez J; Nogueda-Torres B; Reyes-Espinosa F; Bocanegra-García V; Rivera G
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30970549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of novel inhibitors of human kynurenine aminotransferase-I.
    Akladios FN; Nadvi NA; Park J; Hanrahan JR; Kapoor V; Gorrell MD; Church WB
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1579-81. PubMed ID: 22281190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.